Home Clinical Trials Browse by State Browse by City Alzheimer's Disease Guides About Contact

🧩 Paid Alzheimer's Disease Clinical Trials

Browse recruiting alzheimer's disease clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Alzheimer's Disease
Condition

Active Clinical Trials for Alzheimer's Disease

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Alzheimer's Disease

Alzheimer's disease is a progressive neurodegenerative disorder that causes memory loss, cognitive decline, and behavioral changes. Clinical trials investigate disease-modifying therapies, early detection methods, and interventions to slow progression.

Common Symptoms

Memory loss, difficulty with familiar tasks, confusion with time or place, trouble understanding visual images, problems with speaking or writing, changes in personality

Risk Factors

Age, family history, genetic factors (APOE-e4), head injury, cardiovascular risk factors, limited education, social isolation

Treatment Overview

Current treatments include cholinesterase inhibitors and memantine to manage symptoms. Clinical trials are exploring anti-amyloid antibodies, tau-targeting therapies, neuroprotective agents, and lifestyle interventions.

Why Participate?

Alzheimer's clinical trials are critical for finding treatments that can slow or prevent disease progression, offering hope to millions affected by this devastating condition.

Related Conditions

States with Alzheimer's Disease Clinical Trials

Cities with Alzheimer's Disease Clinical Trials

Frequently Asked Questions About Alzheimer's Disease Clinical Trials

Alzheimer's clinical trials test new medications, interventions, and diagnostic tools to treat, slow, or prevent the progression of Alzheimer's disease.
Eligibility varies by study. Some focus on early-stage Alzheimer's, others on mild cognitive impairment, and some include healthy volunteers at risk.
Compensation varies. Studies may offer $50-$200 per visit plus travel reimbursement. Caregiver support is sometimes provided.
Yes, safety is the top priority. Trials have independent monitoring, regular assessments, and participants can withdraw at any time.